IceCure Medical Return on Equity (ROE) Growth & History (ICCM)
IceCure Medical's return on equity was −188.78% for fiscal 2025.
View full IceCure Medical company overviewIceCure Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −188.78% | −28.08 pp |
| 2024 | 2024-12-31 | −160.70% | −82.73 pp |
| 2023 | 2023-12-31 | −77.97% | −13.14 pp |
| 2022 | 2022-12-31 | −64.83% | −4.13 pp |
| 2021 | 2021-12-31 | −60.69% | +22.76 pp |
| 2020 | 2020-12-31 | −83.45% | — |
IceCure Medical quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −44.15% | +31.52 pp |
| Q1 2026 | 2026-03-31 | −48.72% | +6.90 pp |
| Q4 2025 | 2025-12-31 | −46.26% | — |
| Q3 2025 | 2025-09-30 | −63.28% | — |
| Q2 2025 | 2025-06-30 | −75.67% | — |
| Q1 2025 | 2025-03-31 | −55.62% | — |
IceCure Medical return on equity trends
Over the last five fiscal years, IceCure Medical's return on equity decreased from −83.45% to −188.78%, a change of −105.32 percentage points. The latest reported quarter, Q2 2026, shows −44.15%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IceCure Medical source filings ↗